Mind Full of Glycans

We truly have a treat for you - a lecture taught by Thomas Klarić, a member of our team researching the human glycome project. The lecture is titled The Mind Full of Glycans - an insight into the importance of glycans for the neurobiological processes in our brain.

We truly have a treat for you - a lecture taught by Thomas Klarić, a member of our team researching the human glycome project. The lecture is titled The Mind Full of Glycans - an insight into the importance of glycans for the neurobiological processes in our brain.
Glycosylation plays a crucial role in the development and normal functioning of the central nervous system. The latest research indicates that the glyco-profile of the brain is dynamic and can be modified in response to intrinsic and extrinsic factors.
In this lecture, we will examine some of the factors that can affect the glycosylation of brain proteins with a special focus on ageing and inflammation. In addition, we will also explore the link between changes in Immunoglobulin G glycosylation and various neurological disorders.
We’ll start by explaining the difference between GlycanAge and Brain N-glycome as well as why we use one instead of the other when researching neurological disorders. After that, we’ll go into human brain development and specific ailments like brain cancer, MS and PTSD.

Glycan science and biological age
Go deeper with GlycanAge for research and cohort studies, peer-reviewed GlycanAge research case studies, and methodology behind glycan-based biological age testing.

The Future of Healthcare is Preventative, Personalised, and Powered by Glycans
Whether you’re improving your own health, supporting patients, or driving research, GlycanAge helps you turn science into action.

How Partner Clinics Use GlycanAge: 7 Real-World Case Studies From the GlycanAge Network
Uncover the impact of GlycanAge in partner clinics with 7 real-world case studies, highlighting innovative applications and success stories.
September 15, 2026
10 minutes

Peptide Therapy Outcomes: Tracking Whether BPC-157, Thymosin and Others Are Reducing Inflammation
Explore the outcomes of peptide therapy in reducing inflammation with BPC-157, Thymosin, and more. Discover the latest research and findings.
September 14, 2026
10 minutes